| 05/13/2026 3:30 PM | BeyondSpring (1677940) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2026 6:00 AM | BeyondSpring (1677940) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/08/2026 3:57 PM | BeyondSpring (1677940) Issuer Kirkby Matthew (2050147) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/03/2026 4:43 PM | BeyondSpring (1677940) Issuer Fabbio Patrick (1658859) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/25/2026 3:36 PM | BeyondSpring (1677940) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/25/2026 7:30 AM | BeyondSpring (1677940) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/21/2025 3:30 PM | BeyondSpring (1677940) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/17/2025 3:30 PM | BeyondSpring (1677940) Filer | Form 424B5 | |
| 11/12/2025 3:31 PM | BeyondSpring (1677940) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/12/2025 6:00 AM | BeyondSpring (1677940) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/20/2025 7:00 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare GP, LLC (1949027) Reporting Decheng Capital Management II (0) Cayman | Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for BYSI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BeyondSpring and its competitors with MarketBeat's FREE daily newsletter.
|
| 10/15/2025 7:07 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare GP, LLC (1949027) Reporting Decheng Capital Management II (0) Cayman | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/10/2025 4:58 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare GP, LLC (1949027) Reporting Decheng Capital Management II (0) Cayman | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 5:14 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare GP, LLC (1949027) Reporting Decheng Capital Management II (0) Cayman | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/02/2025 7:51 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare GP, LLC (1949027) Reporting Decheng Capital Management II (0) Cayman | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/29/2025 7:06 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/24/2025 5:49 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/23/2025 6:30 AM | BeyondSpring (1677940) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/19/2025 5:03 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/16/2025 6:45 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 6:43 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/08/2025 5:55 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/03/2025 6:57 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/28/2025 7:39 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/25/2025 6:46 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/20/2025 5:35 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/18/2025 11:15 PM | BeyondSpring (1677940) Filer | Form EFFECT | |
| 08/15/2025 6:11 PM | BeyondSpring (1677940) Issuer Cui Xiangmin (1487815) Reporting Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 7:00 AM | BeyondSpring (1677940) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/11/2025 4:07 PM | BeyondSpring (1677940) Issuer Decheng Capital China Life Sciences USD Fund II, L.P. (1650291) Reporting Decheng Capital China Life Sciences USD Fund III, L.P. (1736814) Reporting Decheng Capital Global Healthcare Fund (0) Master Decheng Capital Global Healthcare GP, LLC (1949027) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/03/2025 3:31 PM | BeyondSpring (1677940) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |